Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.8 | GERP -2.9, phastCons 1 |
| Overall | ||
| CADD | 10.27 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 10% | 10 |
| South Asiangrpmax | 9.45% | 11 |
| Middle Eastern | 7.28% | 14 |
| Ashkenazi Jewishnot grpmax-eligible | 5.37% | 19 |
| European (non-Finnish) | 4.93% | 20 |
| Remaining individualsnot grpmax-eligible | 4.71% | 21 |
| Finnishnot grpmax-eligible | 3.58% | 28 |
| Admixed American | 2.8% | 36 |
| African / African-American | 2.45% | 41 |
| East Asian | 0.105% | 955 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RET
- Protein
- p.Ser836=
- Coding
- c.2508C>T
- MANE Select
- NM_020975
- dbSNP
- rs1800862
- Type
- single nucleotide variant
- Location
- chr10:43119646 (GRCh38)
- Gene constraint
- LOEUF 0.24 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 79.27 · 34 PDB
- Residue 836
- the protein kinase domain
Disease context
hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Hirschsprung disease, susceptibility to, 1familial medullary thyroid carcinomamultiple endocrine neoplasia type 2Bpheochromocytomamultiple endocrine neoplasia type 2Amultiple endocrine neoplasiamultiple endocrine neoplasia type 2renal hypodysplasia/aplasia 1
Similar variants
- RET p.Ser836Asn Uncertain significance ★ ⚠ same residue
- RET p.Ser836Cys Uncertain significance ★ ⚠ same residue
- RET c.1759+1G>A Pathogenic/Likely pathogenic ★★ same condition
- RET c.1879+1G>A Pathogenic/Likely pathogenic ★★ same condition
- RET p.Arg180Ter Pathogenic ★★ same condition
- RET p.Arg77Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
- RET p.Arg873Trp Likely pathogenic ★★ same condition
- RET p.Arg897Gln Pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ret-p-ser836 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown